NRC
XPH icon

New Republic Capital’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

New Republic Capital’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4K Buy
+338
New +$19.8K 0.01% 325
2024
Q3 		– Sell
-1,056
Closed -$42K – 271
2024
Q2 		$42K Buy
+1,056
New +$42.8K 0.02% 204

Other funds holding XPH

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EP
Evelyn Partners London $46.9B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New Republic Capital's XPH Position: Q2 2026 in Review

New Republic Capital opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2026: 338 shares worth $22.4K. The stake represents 0.01% of the portfolio and ranks #325 among its holdings. This is a return to the name: New Republic Capital previously reported a position in XPH as recently as Q2 2024.

New Republic Capital first reported a position in XPH in Q2 2024 and has held it in 2 quarters since. The position peaked at $42K in Q2 2024. 92 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • New Republic Capital held 338 shares of State Street SPDR S&P Pharmaceuticals ETF worth $22.4K as of Q2 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new New Republic Capital position in Q2 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of New Republic Capital's portfolio in Q2 2026, its #325 holding.
  • New Republic Capital first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2024 and has held it in 2 quarters since.
  • New Republic Capital's State Street SPDR S&P Pharmaceuticals ETF position peaked at $42K in Q2 2024.
  • 92 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.